Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
AZD1480
Description:
A small-molecule inhibitor of JAK1 and JAK2 kinases investigated for effects on cancer growth and JAK-STAT signaling.
Related topics:
Cytokine Signaling Pathways and Interactions (18%),
Glioma Diagnosis and Treatment (9%)
OpenAlex ID:
keywords/azd1480
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
2009
·
Michael Hedvat
, Dennis Huszar
, et al.
·
Cancer Cell
·
555
PDF
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration
2016
·
Hongwei Qin
, Jessica A. Buckley
, et al.
·
Journal of Neuroscience
·
307
PDF
Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease
2019
·
Jie Zhang
, Dan Wang
, et al.
·
American Journal of Physiology-Lung Cellular and Molecular Physiology
·
218
Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer
2015
·
Nagaraj S. Nagathihalli
, Jason A. Castellanos
, et al.
·
Gastroenterology
·
196
PDF
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
2013
·
Muhammad Furqan
, Nikhil Mukhi
, et al.
·
Biomarker Research
·
192
PDF
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
2010
·
A Scuto
, P Krejci
, et al.
·
Leukemia
·
163
Therapeutic Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of Experimental Autoimmune Encephalomyelitis
2014
·
Yudong Liu
, Andrew T Holdbrooks
, et al.
·
The Journal of Immunology
·
159
Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway
2010
·
Stephanos Ioannidis
, Michelle L. Lamb
, et al.
·
Journal of Medicinal Chemistry
·
135
Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells
2016
·
Nagaraj S. Nagathihalli
, Jason A. Castellanos
, et al.
·
Oncotarget
·
134
PDF
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
2013
·
Elizabeth R. Plimack
, Patricia M. LoRusso
, et al.
·
The Oncologist
·
124
Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480
2011
·
Hong Xin
, Andreas Herrmann
, et al.
·
Cancer Research
·
118
PDF
Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms
2011
·
A Deshpande
, M M Reddy
, et al.
·
Leukemia
·
118
Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models
2020
·
Ru Li
, Yujie Huang
, et al.
·
Nature Communications
·
109
PDF
mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms
2013
·
Costanza Bogani
, Niccolò Bartalucci
, et al.
·
PLoS ONE
·
109
PDF
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice
2017
·
Prerak M. Trivedi
, Kate L. Graham
, et al.
·
Diabetes
·
97
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth
2015
·
Galina Gritsina
, Fang Xiao
, et al.
·
Molecular Cancer Therapeutics
·
96
Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma
2012
·
John de Groot
, Ji Liang
, et al.
·
Oncotarget
·
93
Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
2011
·
Braden C. McFarland
, Jing-Yuan Ma
, et al.
·
Molecular Cancer Therapeutics
·
91
PDF
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes
2015
·
Iva Gudernova
, Iva Vesela
, et al.
·
Human Molecular Genetics
·
80
Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors
2011
·
Arun K Mankan
, Florian R Greten
·
Expert Opinion on Investigational Drugs
·
80
JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth
2015
·
Malabika Sen
, Netanya I. Pollock
, et al.
·
Neoplasia
·
79
PDF
AURKA regulates JAK2–STAT3 activity in human gastric and esophageal cancers
2014
·
Ahmed Katsha
, Janet Arras
, et al.
·
Molecular Oncology
·
79
PDF
Tumour‐associated macrophage‐mediated survival of myeloma cells through STAT3 activation
2017
·
Nathan De Beule
, Kim De Veirman
, et al.
·
The Journal of Pathology
·
73
The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
2011
·
E Derenzini
, M Lemoine
, et al.
·
Blood Cancer Journal
·
72
PDF
Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC
2017
·
Michael D. Hadjidaniel
, Sakunthala Muthugounder
, et al.
·
Oncotarget
·
69
PDF
Show more works
View as search
Works count:
189
Citation count:
5,411
Year
Topic
Type